OTCMKTS:PRVCF PreveCeutical Medical (PRVCF) Stock Forecast, Price & News $0.02 0.00 (0.00%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range$0.02▼$0.0250-Day Range$0.02▼$0.0252-Week Range$0.01▼$0.03Volume47 shsAverage Volume34,693 shsMarket Capitalization$11.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesShort InterestProfileChartCompetitorsHeadlinesShort Interest About PreveCeutical Medical (OTCMKTS:PRVCF) StockPreveCeutical Medical, Inc. engages in licensing, branding, and marketing of nutraceutical and wellness products. The company was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman, and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.Read More Receive PRVCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVCF Stock News HeadlinesMay 30, 2023 | finance.yahoo.comPreveCeutical Medical - Sol-Gel and Uses thereof Patent UpdateApril 24, 2023 | finance.yahoo.comPreveCeutical Medical Launches Clinical Artificial Intelligence DivisionJune 9, 2023 | Edge On The Street (Ad)All Electric Commitment From GM, Volkswagen, Could Put Lithium Sector In A SupercycleMore automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...April 20, 2023 | finance.yahoo.comPreveCeutical Medical Announces Live Interactive Q&A Video ConferenceApril 4, 2023 | finance.yahoo.comPreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe PainMarch 20, 2023 | finance.yahoo.comPreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure CommitteeFebruary 23, 2023 | seekingalpha.comPRVCF PreveCeutical Medical Inc.February 21, 2023 | finance.yahoo.comAppointment of C. Evan Ballantyne to PreveCeutical's Board of DirectorsJune 9, 2023 | Edge On The Street (Ad)All Electric Commitment From GM, Volkswagen, Could Put Lithium Sector In A SupercycleMore automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...February 7, 2023 | finance.yahoo.comPreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical DevelopmentJanuary 14, 2023 | msn.comPreveCeutical, Endosane team up for sol-gel tech use in cannabis therapyJanuary 12, 2023 | finance.yahoo.comPreveCeutical Enters into License Option Agreement with Endosane PharmaceuticalsJanuary 9, 2023 | finance.yahoo.comPreveCeutical Signs Intercompany Sol-Gel License AgreementNovember 23, 2022 | finance.yahoo.comThe Power Play by The Market Herald Releases New Interviews with Eloro Resources, Prospera, Datametrex, Gamelancer Media, Infinity Stone Ventures and PreveCeutical Medical Discussing Their Latest NewsNovember 21, 2022 | finance.yahoo.comPreveCeutical Files Application for D-amino Acid PeptidesNovember 12, 2022 | finanznachrichten.dePreveCeutical Medical Inc.: PreveCeutical Announces Conversion of DebtNovember 12, 2022 | finance.yahoo.comPreveCeutical Announces Conversion of DebtOctober 20, 2022 | finance.yahoo.comAppointment of Kathleen Rotika to PreveCeutical's Board of DirectorsSeptember 17, 2022 | finance.yahoo.comPreveCeutical Announces Resignation of Board of Director MemberSeptember 6, 2022 | finance.yahoo.comAppointment of Sachin Nanavati to PreveCeutical's Board of DirectorsMay 27, 2022 | finance.yahoo.comPreveCeutical Announces Change in Directors and Investor Awareness ServicesMay 9, 2022 | finance.yahoo.comArticle Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of PharmacologyNovember 29, 2021 | finance.yahoo.comPreveCeutical Files International Patent Application for Sol-Gel Cannabinoid Formulation for Antiviral UseNovember 24, 2021 | finance.yahoo.comPreveCeutical Files Provisional Patent Application for D-Amino Acid PeptidesNovember 18, 2021 | finance.yahoo.comPreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest's Sol-Gel Technology for Delivery of CannabinoidsAugust 31, 2021 | finance.yahoo.comPreveCeutical Receives AU$315,338 Research & Development Tax Incentive Cash RefundMarch 17, 2021 | ca.finance.yahoo.comPREVECEUTICAL MED. (18H.BE)See More Headlines PRVCF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRVCF Company Calendar Today6/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PRVCF CUSIPN/A CIKN/A Webwww.preveceutical.com Phone(604) 416-7777Fax778-945-6290EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-2.18Miscellaneous Outstanding Shares535,300,000Free FloatN/AMarket Cap$11.67 million OptionableNot Optionable Beta0.87 Key ExecutivesStephen van DeventerChairman, Chief Executive & Financial OfficerMakarand JawadekarPresident, Director & Chief Science OfficerHarry ParekhChief Research OfficerAlicia RebmanMarketing DirectorKey CompetitorsGreen Organic DutchmanOTCMKTS:TGODFReNeuron GroupOTCMKTS:RNUGFPoxelOTCMKTS:PXXLFBZAMOTCMKTS:BZAMFVenus ConceptNASDAQ:VEROView All Competitors PRVCF Stock - Frequently Asked Questions How have PRVCF shares performed in 2023? PreveCeutical Medical's stock was trading at $0.0179 on January 1st, 2023. Since then, PRVCF shares have increased by 21.8% and is now trading at $0.0218. View the best growth stocks for 2023 here. What is PreveCeutical Medical's stock symbol? PreveCeutical Medical trades on the OTCMKTS under the ticker symbol "PRVCF." How do I buy shares of PreveCeutical Medical? Shares of PRVCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is PreveCeutical Medical's stock price today? One share of PRVCF stock can currently be purchased for approximately $0.02. How much money does PreveCeutical Medical make? PreveCeutical Medical (OTCMKTS:PRVCF) has a market capitalization of $11.67 million. How can I contact PreveCeutical Medical? PreveCeutical Medical's mailing address is 1177 West Hastings Street Suite 2200, Vancouver A1, V6E2K3. The official website for the company is www.preveceutical.com. The company can be reached via phone at (604) 416-7777, via email at ir@preveceutical.com, or via fax at 778-945-6290. This page (OTCMKTS:PRVCF) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PreveCeutical Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.